Rare diseases
Investigational molecules
Locations
Largo Ugo Dossena, 2, 26013 Crema, Italy
ASST Ospedale Maggiore di Crema in Crema, Italy specialises in clinical trials of conditions such as Oesophageal adenocarcinoma, Non-small cell lung cancer, Metastatic malignant melanoma, and other specialisations. This site conducts important research.
The ASST Ospedale Maggiore di Crema is conducting research focused on advanced HER2‑negative and PD‑L1 positive gastroesophageal adenocarcinoma, aiming to improve outcomes through a switch‑maintenance strategy that combines chemotherapy and immunotherapy.
Findings aim to extend progression‑free survival for patients with this digestive system cancer.
In the field of skin cancer, the site is evaluating a novel antibody, ABP 206, against the established checkpoint inhibitor nivolumab for patients with unresectable or metastatic melanoma who have not received prior systemic therapy.
The study seeks to determine whether the new agent can provide a more effective treatment option for patients with advanced melanoma.
Clinical trials registered at this site – none is enrolling right now.
ItalyItalyItalyGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
